AI Technology
Interview with Sware: Modicus Prime Image Analysis for Quality Assurance
Recently, Modicus Prime Founder and CEO Taylor Chartier discussed the game-changing potential of Artificial Intelligence (AI) for pharmaceutical companies with Sware’s VP of Marketing, Terri Leigh Rhody. Featured in the blog post “Res_Q and AI: Modicus Prime Image Analysis for Quality Assurance,” Chartier focuses on how the pharmaceutical industry is catching the wave of using in-line, real-time AI technology to achieve efficient, cost-effective commercial monitoring of the manufacturing process with software like Modicus Prime’s mpVision – which enables real-time AI classification through computer vision, ensuring comprehensive quality control across R&D and manufacturing.
